JP2005527592A5 - - Google Patents

Download PDF

Info

Publication number
JP2005527592A5
JP2005527592A5 JP2003585708A JP2003585708A JP2005527592A5 JP 2005527592 A5 JP2005527592 A5 JP 2005527592A5 JP 2003585708 A JP2003585708 A JP 2003585708A JP 2003585708 A JP2003585708 A JP 2003585708A JP 2005527592 A5 JP2005527592 A5 JP 2005527592A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
ester
acid
composition according
ketoalkanoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003585708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005527592A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/012135 external-priority patent/WO2003088956A1/en
Publication of JP2005527592A publication Critical patent/JP2005527592A/ja
Publication of JP2005527592A5 publication Critical patent/JP2005527592A5/ja
Pending legal-status Critical Current

Links

JP2003585708A 2002-04-17 2003-04-17 α−ケトアルカン酸または−エステルもしくは−アミドを用いる腸閉塞の処置方法 Pending JP2005527592A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37368002P 2002-04-17 2002-04-17
PCT/US2003/012135 WO2003088956A1 (en) 2002-04-17 2003-04-17 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide

Publications (2)

Publication Number Publication Date
JP2005527592A JP2005527592A (ja) 2005-09-15
JP2005527592A5 true JP2005527592A5 (https=) 2006-05-18

Family

ID=29251059

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003585708A Pending JP2005527592A (ja) 2002-04-17 2003-04-17 α−ケトアルカン酸または−エステルもしくは−アミドを用いる腸閉塞の処置方法
JP2003585707A Pending JP2005526832A (ja) 2002-04-17 2003-04-17 α−ケトアルカン酸エステルまたは−アミドおよび乳酸または乳酸塩を含有する医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2003585707A Pending JP2005526832A (ja) 2002-04-17 2003-04-17 α−ケトアルカン酸エステルまたは−アミドおよび乳酸または乳酸塩を含有する医薬組成物

Country Status (8)

Country Link
US (2) US20030232884A1 (https=)
EP (2) EP1496883A1 (https=)
JP (2) JP2005527592A (https=)
AT (1) ATE306257T1 (https=)
AU (2) AU2003230996A1 (https=)
CA (2) CA2481753A1 (https=)
DE (1) DE60301878T2 (https=)
WO (2) WO2003088956A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002563A2 (en) * 2003-06-13 2005-01-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Eduction Method for treating alcoholic hepatitis
US7464564B2 (en) * 2003-09-22 2008-12-16 Dippin' Dots, Inc. Method and apparatus for combining cookie dough and ice cream
US20050106301A1 (en) * 2003-09-24 2005-05-19 Curt Jones Method and apparatus for cryogenically manufacturing ice cream
US20070276037A1 (en) * 2003-10-27 2007-11-29 Woo Yi-Ping J Cytoprotective Effects of Ethyl Pyruvate
US7316122B1 (en) 2004-01-06 2008-01-08 Dippin' Dots, Inc. Tray for producing particulate food products
US20060062877A1 (en) * 2004-09-21 2006-03-23 Curt Jones Method and apparatus for storing food products
US20060093719A1 (en) * 2004-11-01 2006-05-04 Dippin' Dots, Inc. Particulate ice cream dot sandwich
US20060093714A1 (en) * 2004-11-01 2006-05-04 Dippin' Dots, Inc. Particulate ice cream dot cake
EP1874407B1 (en) * 2005-04-15 2015-09-09 Biomac Privatinstitut für medizinische und Zahnmedizinische Forschung, Entwicklung und Diagnostik GmbH Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents
US7332315B2 (en) * 2005-08-17 2008-02-19 Colgate-Palmolive Company Method to remove bisulfite by-products from enzyme compositions
US20070134394A1 (en) * 2005-12-12 2007-06-14 Dippin' Dots, Inc. Method of manufacturing particulate ice cream for storage in conventional freezers
US20070140044A1 (en) * 2005-12-15 2007-06-21 Dippin' Dots, Inc. Combined particulate and traditional ice cream
US20070140043A1 (en) * 2005-12-16 2007-06-21 Stan Jones Method and apparatus of combining food particles and ice cream
JP2009533433A (ja) * 2006-04-12 2009-09-17 アレクサンダー，ランヤ，エル． ピルビン酸アルキルエステルを含む組成物とその使用
US8603513B2 (en) * 2007-06-28 2013-12-10 The Procter & Gamble Company Article comprising calcium for reducing the production of TSST-1
CA2737522A1 (en) * 2008-09-19 2010-04-08 Cytokine Pharmasciences, Inc. Guanylhydrazones for treatment of postoperative intestinal inflammation
CN106727320A (zh) * 2017-01-13 2017-05-31 江苏长泰药业有限公司 一种用于修复鼻粘膜、降低过敏反应、抗炎作用的组合物

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984556A (en) * 1973-01-19 1976-10-05 Sandoz, Inc. Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3988470A (en) * 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4415576A (en) * 1981-04-01 1983-11-15 Montefiore Hospital Method for preventing body fat deposition in mammals
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals
US4812479A (en) * 1981-04-01 1989-03-14 The Montefiore Hospital Society Of Western Pennsylvania, Inc. Method for preventing body fat deposition in mammals
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
US4645764A (en) * 1981-04-01 1987-02-24 Montefiore Hospital Method for preventing body fat deposition in animals
EP0215138B1 (fr) * 1985-09-06 1991-01-16 Societe Des Produits Nestle S.A. Préservation des tissus vivants
JPS63502274A (ja) * 1985-12-18 1988-09-01 ビ−チ，リチヤ−ド　エル Ｌ↓−乳酸および／またはピルビン酸アニオンを用いた流体式治療法
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US6051609A (en) * 1997-09-09 2000-04-18 Tristrata Technology, Inc. Additives enhancing the effect of therapeutic agents
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
KR910000101A (ko) * 1988-06-02 1991-01-29 유다까 미시마 효소형성 억제제
US5147650A (en) * 1988-07-29 1992-09-15 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US4981687A (en) * 1988-07-29 1991-01-01 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US4874790A (en) * 1988-08-15 1989-10-17 Montefiore Hospital Association Of Western Pennsylvania Method for improving the glucose metabolism of an animal having diabetic tendencies
US5075210A (en) * 1989-12-21 1991-12-24 The Regents Of The University Of California Preservation of the heart for transplantation
US5066578A (en) * 1989-12-21 1991-11-19 The Regents Of The University Of California Long-term preservation of organs for transplantation
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5134162A (en) * 1990-12-24 1992-07-28 The Montefiore Hospital Association Of Western Pennsylvania Method for lowering high blood cholesterol levels in hyperlipidemic animals and confections as the ingestion medium
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5294641A (en) * 1991-11-27 1994-03-15 Montefiore - University Hospital Method for treating a medical patient for cardiac trauma
US5508308A (en) * 1992-04-16 1996-04-16 Abbott Laboratories Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
US5702880A (en) * 1993-06-04 1997-12-30 Biotime, Inc. Blood substitute comprising 0-5 mM K+
US5395822A (en) * 1993-09-20 1995-03-07 Izumi; Yukitoshi Use of pyruvate to prevent neuronal degeneration associated with ischemia
US5612374A (en) * 1994-02-14 1997-03-18 Ronald T. Stanko Inhibiting growth of mammary adenocarcinoma
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
US5480909A (en) * 1994-08-08 1996-01-02 University Of Pittsburgh Medical Center Method for inhibiting generation of free-radicals
US5801198A (en) * 1995-07-13 1998-09-01 University Of Pittsburgh Medical Center Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US5667962A (en) * 1996-03-18 1997-09-16 Case Western Reserve University Pyruvate thiolester for the prevention of reperfusion injury
US5876916A (en) * 1996-03-18 1999-03-02 Case Western Reserve University Pyruvate compounds and methods for use thereof
US6086789A (en) * 1996-03-18 2000-07-11 Case Western Reserve University Medical uses of pyruvates
US5843024A (en) * 1996-05-17 1998-12-01 Breonics, Inc. Solution and process for resuscitation and preparation of ischemically damaged tissue
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US6417231B1 (en) * 1996-12-23 2002-07-09 Frank L. Greenway Method and composition for delivering therapeutically effective amounts of pyruvate to a mammal
GB9724813D0 (en) * 1997-11-25 1998-01-21 Univ Nottingham Reducing muscle fatigue
CN1377266A (zh) * 1999-10-07 2002-10-30 安瑟斯生命科学公司 丙酮酸酯组合物和其在缺血和灌流后复苏中的应用方法

Similar Documents

Publication Publication Date Title
JP2005527592A5 (https=)
JP2004528307A5 (https=)
JP2005514441A5 (https=)
Galanakis et al. Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity
CA3126264C (en) A method for side effect reduction in the use of statins via physiologically synthesized glutathione
JP2009545527A (ja) 粘膜炎の治療用の組成物及び方法
JP2008538586A5 (https=)
MY153620A (en) Novel sulphur containing lipids for use as food supplementor as medicament
AU2003228593B2 (en) Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
JP2008543854A (ja) 炎症状態を治療するための組成物および方法
JP2008525445A5 (https=)
JP2007523049A5 (https=)
EP0977561A1 (en) Glucosamine fatty acid compositions and their use
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
KR890011823A (ko) 벤조일 페닐아세트산 유도체 약제 조성물
JP2003526622A5 (https=)
RU2012142811A (ru) Фармацевтические композиции и пероральные дозированные формы пролекарства леводопы и способы применения
JP2006520801A5 (https=)
CA2384502A1 (en) Use of .alpha.-linolenic acid metabolites for treatment or prevention of cancer
JP2006516272A5 (https=)
CA2692191C (en) Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
WO2009138437A1 (en) Salicylate conjugates useful for treating metabolic disorders
RU2006101675A (ru) Потребляемая пленка против зубного налета, освежающая дыхание
JP2006219454A5 (https=)
KR890001535A (ko) 요독증의 치료에 유용한 약학 조성물